MedTrace Logo

EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms

NCT00991614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2012-03-29

No results posted yet for this study

Summary

The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.

Conditions

  • Duodenal Obstruction
  • Gastric Outlet Obstruction

Interventions

DEVICE

EVOLUTION® Duodenal Stent

EVOLUTION® Duodenal Stent

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Professor Guido Costamagna, MD · U.O. Endoscopia Digestiva Chirurgica

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-06-30
Completion
2012-03-31

Countries

  • Australia
  • Canada
  • Czechia
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00991614 on ClinicalTrials.gov